Findings indicated that although studies generally met st and ards in several quality areas , there is still room for improvement .
Areas for improvement include establishing representativeness , adequately describing clinical and demographic characteristics of the sample , and presenting better descriptions of important aspects of test and reference st and ard execution .
In addition , study quality has not appreciably improved since the publication of the STARD Statement in 2003 .
Despite the popularity of the PTSD Checklist ( PCL ) as a clinical screening test , there has been no comprehensive quality review of studies evaluating its diagnostic accuracy .
Posttraumatic stress disorder among mothers of pediatric cancer survivors: diagnosis, comorbidity, and utility of the PTSD checklist as a screening instrument.
OBJECTIVE To examine posttraumatic stress disorder ( PTSD ) in mothers of survivors of childhood cancer . Comorbidity of anxiety and depressive disorders , prevalence of sub clinical PTSD , and the utility of a self-report measure as a screening instrument for PTSD were also investigated . METHOD Mothers ( n = 65 ) completed a question naire self-report PTSD checklist ( PCL-C ) .  Mothers were administered several modules of the SCID : nonpatient edition by telephone , including the PTSD , Generalized Anxiety , and Major Depressive Disorder modules . RESULTS We diagnosed 6.2 % of the sample with current PTSD . An additional 20 % had sub clinical PTSD . One of four mothers with PTSD diagnoses had a comorbid diagnosis of an anxiety and depressive disorder . The PCL-C evidence d diagnostic utility as a screening instrument . However , a moderate number of false-positives would result if the recommended cut-off on the instrument was used . CONCLUSIONS The PCL-C had diagnostic utility in screening mothers of childhood cancer survivors . The presence of comorbid diagnoses such as anxiety and depression should be examined
Findings indicated that although studies generally met st and ards in several quality areas , there is still room for improvement .
Areas for improvement include establishing representativeness , adequately describing clinical and demographic characteristics of the sample , and presenting better descriptions of important aspects of test and reference st and ard execution .
In addition , study quality has not appreciably improved since the publication of the STARD Statement in 2003 .
Despite the popularity of the PTSD Checklist ( PCL ) as a clinical screening test , there has been no comprehensive quality review of studies evaluating its diagnostic accuracy .